Mavacamten improves obstruction in adolescents with hypertrophic cardiomyopathy
Adolescent patients with obstructive hypertrophic cardiomyopathy (HCM) who received the drug mavacamten saw a significant improvement in left ventricular outflow tract (LVOT) gradient, a measure of blood flow obstruction ...
Mar 30, 2026
0
3









